Redefining the Positive Margin in Pancreatic Cancer: Impact on Patterns of Failure, Long-Term Survival and Adjuvant Therapy.

about

Redefining the Positive Margin in Pancreatic Cancer: Impact on Patterns of Failure, Long-Term Survival and Adjuvant Therapy.

Item

http://www.wikidata.org/entity/Q48035210

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Redefining the Positive Margin ...... Survival and Adjuvant Therapy.

@en

Redefining the Positive Margin ...... Survival and Adjuvant Therapy.

@nl

type

Item

label

Redefining the Positive Margin ...... Survival and Adjuvant Therapy.

@en

Redefining the Positive Margin ...... Survival and Adjuvant Therapy.

@nl

prefLabel

Redefining the Positive Margin ...... Survival and Adjuvant Therapy.

@en

Redefining the Positive Margin ...... Survival and Adjuvant Therapy.

@nl

P1476

Redefining the Positive Margin ...... Survival and Adjuvant Therapy.

@en

P2093

Andrew Eugene Hendifar

http://www.w3.org/2001/XMLSchema#string

Arsen Osipov

http://www.w3.org/2001/XMLSchema#string

Deepti Dhall

http://www.w3.org/2001/XMLSchema#string

Jason Naziri

http://www.w3.org/2001/XMLSchema#string

Joanne Rutgers

http://www.w3.org/2001/XMLSchema#string

Nicholas Nissen

http://www.w3.org/2001/XMLSchema#string

Quanlin Li

http://www.w3.org/2001/XMLSchema#string

Richard Tuli

http://www.w3.org/2001/XMLSchema#string

Shefali Chopra

http://www.w3.org/2001/XMLSchema#string

P2860

Synoptic reporting improves histopathological assessment of pancreatic resection specimens.

Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group.

A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer.

Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database.

Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial.

Biology and management of pancreatic cancer.

Early recurrence of pancreatic cancer after resection and during adjuvant chemotherapy.

End points for adjuvant therapy trials: has the time come to accept disease-free survival as a surrogate end point for overall survival?

Analysis of local control in patients receiving IMRT for resected pancreatic cancers

Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively collected database at the Johns Hopkins Hospital.

P2888

s10434-017-6076-z

P304

3674-3682

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1245/S10434-017-6076-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1091482221

http://www.w3.org/2001/XMLSchema#string

P698

28871564

http://www.w3.org/2001/XMLSchema#string